333 related articles for article (PubMed ID: 9791143)
41. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of aberrant crypt foci by chemopreventive agents.
Olivo S; Wargovich MJ
In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
[TBL] [Abstract][Full Text] [Related]
43. Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis.
Orii S; Yamaguchi T; Anzai H; Saito S; Chiba T; Suzuki K
J Exp Clin Cancer Res; 2003 Mar; 22(1):41-6. PubMed ID: 12725321
[TBL] [Abstract][Full Text] [Related]
44. Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence.
Sedivy R; Wolf B; Kalipciyan M; Steger GG; Karner-Hanusch J; Mader RM
Br J Cancer; 2000 Apr; 82(7):1276-82. PubMed ID: 10755401
[TBL] [Abstract][Full Text] [Related]
45. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
[TBL] [Abstract][Full Text] [Related]
46. Microsatellite instability in aberrant crypt foci from human colons.
Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
[TBL] [Abstract][Full Text] [Related]
47. Aberrant crypt foci: what we know and what we need to know.
Gupta AK; Pretlow TP; Schoen RE
Clin Gastroenterol Hepatol; 2007 May; 5(5):526-33. PubMed ID: 17433788
[TBL] [Abstract][Full Text] [Related]
48. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
[TBL] [Abstract][Full Text] [Related]
49. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
50. Expression of ras oncogene mRNA and protein in aberrant crypt foci.
Stopera SA; Bird RP
Carcinogenesis; 1992 Oct; 13(10):1863-8. PubMed ID: 1423846
[TBL] [Abstract][Full Text] [Related]
51. K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
[TBL] [Abstract][Full Text] [Related]
52. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
53. Aberrant crypt foci and microadenoma as markers for colon cancer.
Archer MC; Bruce WR; Chan CC; Corpet DE; Medline A; Roncucci L; Stamp D; Zhang XM
Environ Health Perspect; 1992 Nov; 98():195-7. PubMed ID: 1486848
[TBL] [Abstract][Full Text] [Related]
54. Biology and diagnosis of aberrant crypt foci.
Lopez-Ceron M; Pellise M
Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
[TBL] [Abstract][Full Text] [Related]
55. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis?
Pretlow TP
Gastroenterology; 1995 Feb; 108(2):600-3. PubMed ID: 7835604
[No Abstract] [Full Text] [Related]
56. B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.
Inoue A; Okamoto K; Fujino Y; Nakagawa T; Muguruma N; Sannomiya K; Mitsui Y; Takaoka T; Kitamura S; Miyamoto H; Okahisa T; Fujimori T; Imoto I; Takayama T
Br J Cancer; 2015 Jan; 112(2):403-12. PubMed ID: 25314065
[TBL] [Abstract][Full Text] [Related]
57. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
[TBL] [Abstract][Full Text] [Related]
58. Carcinoembryonic antigen in human colonic aberrant crypt foci.
Pretlow TP; Roukhadze EV; O'Riordan MA; Chan JC; Amini SB; Stellato TA
Gastroenterology; 1994 Dec; 107(6):1719-25. PubMed ID: 7958683
[TBL] [Abstract][Full Text] [Related]
59. Aberrant crypt foci: A review.
Fenoglio-Preiser CM; Noffsinger A
Toxicol Pathol; 1999; 27(6):632-42. PubMed ID: 10588543
[No Abstract] [Full Text] [Related]
60. A multicenter study of prevalence and risk factors for aberrant crypt foci.
Mutch MG; Schoen RE; Fleshman JW; Rall CJ; Dry S; Seligson D; Charabaty A; Chia D; Umar A; Viner J; Hawk E; Pinsky PF
Clin Gastroenterol Hepatol; 2009 May; 7(5):568-74. PubMed ID: 19418605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
